This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Naoko Hiura: Innovator in Monoclonal Antibody Research
Introduction
Naoko Hiura is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents to her name, her work has the potential to impact therapeutic and diagnostic applications.
Latest Patents
One of her latest patents is focused on an Anti-CD27 antibody. This invention provides a monoclonal antibody that specifically recognizes CD27 containing an O-linked sugar chain to which galactose is not bound. It binds to the extracellular region of CD27 and offers a method for utilizing this antibody. The invention includes a hybridoma that produces the antibody, a DNA encoding the antibody, and a vector comprising the DNA. Additionally, it outlines a process for producing the antibody or its fragments and describes a diagnostic or therapeutic agent that includes the antibody as an active ingredient.
Another significant patent addresses a preventive and/or therapeutic agent for neutrophilic inflammatory diseases. This invention comprises a bicyclic heterocyclic compound as the active ingredient. The compound is represented by a specific formula that includes various substituents, showcasing the complexity and innovation behind her research.
Career Highlights
Naoko Hiura is associated with Kyowa Hakko Kirin Co., Limited, a company known for its advancements in biopharmaceuticals. Her work at this organization has allowed her to focus on innovative solutions in the medical field.
Collaborations
She has collaborated with notable coworkers, including Katsuhiro Mori and Tsuguo Kubota. These partnerships have likely contributed to the success of her research and patent applications.
Conclusion
Naoko Hiura's contributions to monoclonal antibody research exemplify the innovative spirit of modern biotechnology. Her patents not only advance scientific knowledge but also hold promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile